Universität zu Köln

Journal Article

Shimabukuro-Vornhagen, Alexander, Garcia-Marquez, Maria, Fischer, Rieke N., Iltgen-Breburda, Juliane, Fiedler, Anne, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Rappl, Gunter, Abken, Hinrich, Lehmann, Clara, Herling, Marco, Wolf, Dominik, Faetkenheuer, Gerd, Rubbert-Roth, Andrea, Hallek, Michael, Theurich, Sebastian ORCID: 0000-0001-5706-8258 and von Bergwelt-Baildon, Michael (2017). Antigen-presenting human B cells are expanded in inflammatory conditions. J. Leukoc. Biol., 101 (2). S. 577 - 588. HOBOKEN: WILEY. ISSN 1938-3673

Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Weber, Tanja M., Klein-Gonzalez, Nela, Thelen, Martin ORCID: 0000-0002-2785-9726, Garcia-Marquez, Maria, Chakupurakal, Geothy, Fiedler, Anne, Schloesser, Hans A., Fischer, Rieke, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Shimabukuro-Vornhagen, Alexander and von Bergwelt-Baildon, Michael (2017). CD40-activated B cells induce anti-tumor immunity in vivo. Oncotarget, 8 (17). S. 27740 - 27754. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Lechner, Axel, Schloesser, Hans, Rothschild, Sacha I., Thelen, Martin ORCID: 0000-0002-2785-9726, Reuter, Sabrina, Zentis, Peter, Shimabukuro-Vornhagen, Alexander, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Garcia-Marquez, Maria, Tharun, Lars, Quaas, Alexander, Schauss, Astrid, Isensee, Joerg ORCID: 0000-0002-3390-0051, Hucho, Tim ORCID: 0000-0002-4147-9308, Huebbers, Christian ORCID: 0000-0002-2934-1218, von Bergwelt-Baildon, Michael and Beutner, Dirk (2017). Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Oncotarget, 8 (27). S. 44418 - 44434. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Thelen, Martin ORCID: 0000-0002-2785-9726, Schloesser, Hans Anton, Haustein, Natalie, Reuter, Sabrina, Garcia-Marquez, Maria, Lechner, Axel, Kobold, Sebastian, Rataj, Felicitas, Utermoehlen, Olaf, Chakupurakal, Geothy, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Hallek, Michael, Abken, Hinrich, Shimabukuro-Vornhagen, Alexander and von Bergwelt-Baildon, Michael (2017). Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy. Cancer Immunol. Res., 5 (9). S. 730 - 744. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2326-6074

Schloesser, Hans A., Drebber, Uta, Kloth, Michael, Thelen, Martin ORCID: 0000-0002-2785-9726, Rothschild, Sacha I., Haase, Simon, Garcia-Marquez, Maria, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Berlth, Felix ORCID: 0000-0002-3780-0728, Urbanski, Alexander, Alakus, Hakan, Schauss, Astrid, Shimabukuro-Vornhagen, Alexander, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Warnecke-Ebertz, Ute, Stippel, Dirk L., Zippelius, Alfred, Buettner, Reinhard, Hallek, Michael, Hoelscher, Arnulf H., Zander, Thomas, Moenig, Stefan P. and von Bergwelt-Baildon, Michael (2016). Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma. OncoImmunology, 5 (5). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Theurich, Sebastian ORCID: 0000-0001-5706-8258, Schlaak, Max, Steguweit, Harold, Heukamp, Lukas C., Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Kurschat, Peter, Rabenhorst, Anja, Hartmann, Karin ORCID: 0000-0002-4595-8226, Schloesser, Hans, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Holtick, Udo, Hallek, Michael, Stadler, Rudolf and von Bergwelt-Baildon, Michael (2016). Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma. J. Clin. Oncol., 34 (12). S. E110 - 7. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Gonzalez, Nela Klein, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Balkow, Sandra, Kondo, Eisei ORCID: 0000-0003-0995-9405, Boelck, Birgit, Weber, Tanja, Garcia-Marquez, Maria, Grabbe, Stephan, Bloch, Wilhelm, von Bergwelt-Baildon, Michael and Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294 (2015). In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. OncoImmunology, 4 (9). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Schloesser, Hans A., Gryschok, Luise, Malcher, Joke, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Garcia-Marquez, Maria, Herbold, Till, Neuhaus, Laura S., Becker, Hans J., Fiedler, Anne, Scherwitz, Pascal, Koslowsky, Thomas, Hake, Roland, Stippel, Dirk L., Hoelscher, Arnulf H., Eidt, Sebastian, Hallek, Michael, Theurich, Sebastian ORCID: 0000-0001-5706-8258 and von Bergwelt-Baildon, Michael S. (2014). Characterization of tumor-associated B-cell subsets in patients with colorectal cancer. Oncotarget, 5 (13). S. 4651 - 4665. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Zoghi, Shahram, Liebig, Tanja M., Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Chemitz, Jens, Draube, Andreas, Kochanek, Matthias, Blaschke, Florian, Pallasch, Christian, Holtick, Udo, Scheid, Christof, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Hallek, Michael and von Bergwelt-Baildon, Michael S. (2014). Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity. J. Immunol., 193 (10). S. 5294 - 5306. BETHESDA: AMER ASSOC IMMUNOLOGISTS. ISSN 1550-6606

Garcia-Marquez, Maria A., Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Kochanek, Matthias, Weber, Tanja, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Dauben, Alexandra, Dzionek, Andrzej, Reinhard, Claudia and von Bergwelt-Baildon, Michael (2014). A multhnerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells. Cytotherapy, 16 (11). S. 1537 - 1545. OXFORD: ELSEVIER SCI LTD. ISSN 1477-2566

Garcia-Marquez, Maria A., Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Draube, Andreas and von Bergwelt-Baildon, Michael (2012). Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging? Immunotherapy, 4 (10). S. 991 - 995. LONDON: FUTURE MEDICINE LTD. ISSN 1750-743X